https://blogs.mercola.com:443/sites/vitalvotes/archive/2005/03/03/ms-wonder-drug-questioned-before-approval.aspxWhen I shared the news with you that Tysabri -- that so-called "wonder drug" for multiple sclerosis (MS) -- had been pulled from the market Monday by Biogen Idec and Elan Corp., I suspected there was more to the story than was being first reported. ParticularlyenCommunityServer 2008.5 SP1 (Debug Build: 31106.3070)